Harmony Biosciences Holdings, Inc. (HRMY) vs Maravai LifeSciences Holdings, Inc. (MRVI)

A side-by-side comparison of Harmony Biosciences Holdings, Inc. and Maravai LifeSciences Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — HRMY vs MRVI

growth of $100 · dividends reinvested · last 6y
HRMY -8.6% (-1.5%/yr)MRVI -71.5% (-18.9%/yr)HRMY compounded faster over this window
050100150200Start $100202120222023202420252026$91$29
HRMY MRVI

HRMY vs MRVI: by the numbers

  • •HRMY is the larger company ($2.29B vs $2.24B market cap).
  • •HRMY is profitable (18.88% net margin) while MRVI runs a net loss (-37.07%).
  • •HRMY grew revenue faster over the past five years (32.47% vs -17.68% CAGR).

Metrics side by side

Valuation

MetricHRMYMRVI
P/E ratio12.82N/A
Forward P/E10.02N/A
P/S ratio2.3810.74
P/B ratio2.2910.95
EV / EBITDA7.3915.51
FCF yield15.52%N/A

Profitability

MetricHRMYMRVI
Gross margin75.42%17.98%
Operating margin24.03%-3.63%
Net margin18.88%-37.07%
ROE18.14%-37.82%
ROIC14.96%16.96%

Growth (annualized)

MetricHRMYMRVI
Revenue CAGR (5Y)32.47%-17.68%
FCF CAGR (5Y)48.43%N/A
Total return CAGR (5Y)0.91%-27.63%

Frequently asked

Which has grown faster, HRMY or MRVI?
Over the past five years, HRMY grew revenue faster — HRMY at a 32.47% CAGR versus MRVI at -17.68%.
Is HRMY or MRVI more profitable?
HRMY runs the higher net margin — HRMY at 18.88% versus MRVI at -37.07%.
How have HRMY and MRVI total returns compared?
Over the past 5 years, HRMY delivered 0.91% and MRVI delivered -27.63% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.